- Home
- NYMT vs NGNE Comparison
NYMT vs NGNE Comparison
Compare NYMT & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMT
- NGNE
- Stock Information
- Founded
- NYMT 2003
- NGNE 2003
- Country
- NYMT United States
- NGNE United States
- Employees
- NYMT N/A
- NGNE N/A
- Industry
- NYMT Real Estate Investment Trusts
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- NYMT Real Estate
- NGNE Health Care
- Exchange
- NYMT Nasdaq
- NGNE Nasdaq
- Market Cap
- NYMT 539.9M
- NGNE 471.1M
- IPO Year
- NYMT 2004
- NGNE N/A
- Fundamental
- Price
- NYMT $5.96
- NGNE $34.52
- Analyst Decision
- NYMT Buy
- NGNE Strong Buy
- Analyst Count
- NYMT 5
- NGNE 6
- Target Price
- NYMT $7.88
- NGNE $63.80
- AVG Volume (30 Days)
- NYMT 934.7K
- NGNE 353.3K
- Earning Date
- NYMT 10-30-2024
- NGNE 11-15-2024
- Dividend Yield
- NYMT 13.42%
- NGNE N/A
- EPS Growth
- NYMT N/A
- NGNE N/A
- EPS
- NYMT N/A
- NGNE 0.18
- Revenue
- NYMT $252,541,000.00
- NGNE $925,000.00
- Revenue This Year
- NYMT N/A
- NGNE N/A
- Revenue Next Year
- NYMT $26.56
- NGNE N/A
- P/E Ratio
- NYMT N/A
- NGNE $189.06
- Revenue Growth
- NYMT 139.48
- NGNE N/A
- 52 Week Low
- NYMT $5.14
- NGNE $12.49
- 52 Week High
- NYMT $9.67
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- NYMT 57.22
- NGNE 35.74
- Support Level
- NYMT $5.57
- NGNE $35.60
- Resistance Level
- NYMT $6.23
- NGNE $43.24
- Average True Range (ATR)
- NYMT 0.22
- NGNE 6.02
- MACD
- NYMT 0.06
- NGNE -2.86
- Stochastic Oscillator
- NYMT 75.23
- NGNE 0.00
About NYMT New York Mortgage Trust Inc.
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.